ABCC1 and cancer: In addition to anti-cancer agents, MRP1 can reduce the efficacy of a wide variety of drugs commonly used for various metabolic diseases and neurological disorders, as well as antivirals, antimalarials, antibiotics, antidepressants, and anti-human immunodeficiency virus (HIV) drugs [1,25,26].